Menu
  • Join
  • Login
  • Contact
 

Library

FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.

2019 FIP global vaccination advocacy toolkit
2019 mHealth: Use of mobile health technologies in pharmacy practice
This report contains the findings of a survey of FIP member organisations in 22 countries about the use of mHealth applications by pharmacists and apps developed or endorsed by those organisations. Many mHealth applications have been endorsed by professional bodies around the world. The report highlights some of these endorsed applications and identifies gaps for future development.
2019 Beating non-communicable diseases in the community: The contribution of pharmacists

The value of involving pharmacists in the prevention, early detection and management of non-communicable diseases is highlighted in this report. It also reviewed published evidence of the impact of pharmacists in the fight against NCDs and contains recommended actions for national and local associations of pharmacists.

2018 Pharmacists supporting women and responsible use of medicines

In this reference document, attention is paid to the fact that women as informal caregivers considerably lighten the load of the healthcare labour force, often playing a crucial and underappreciated role in providing healthcare to families and communities. The evidence reveals that health systems rely on women’s contributions as important caregivers, but they do not adequately support women in this endeavour. This document also provides an overview of gender-based policies and a brief overview of current initiatives in this area.

2018 Use of medicines by the elderly: The role of pharmacy in promoting adherence

New medicines services, more counselling when a medicine is supplied again, dosage administration aids and reminder systems are among a list of pharmacy interventions with evidence of improving adherence to medication in elderly patients with chronic conditions. This report is intended as a tool to promote the role pharmacists can play in tackling adherence issues to governments and other agencies.

2018 Pharmacists in the supply chain: The role of the medicines expert in ensuring quality and availability

This report was released in a landscape of challenges such as substandard and falsified medicines, and a shortage of human resources in the health supply chain. The need to ensure effective and safe medicines supply prompted FIP to take a close look at the actual role of pharmacists in pharmaceutical supply chains. This report aims to provide a foundation from which improvement can develop. The report points out that investment in training and education are needed to strengthen pharmacists’ roles in supply chains, and it details the competencies that these roles require.

2017 Reducing harm associated with drugs of abuse: The role of pharmacists

The value of involving pharmacists in reducing harm from drugs of abuse is highlighted in this report, which describes harm reduction services such as needle exchange and opioid substitution in different regions and countries, including Europe, the USA, Canada, central Asia and the Middle East. In addition, against a background of shifting policies on marijuana around the world, the report also addresses questions over the supply from pharmacies of marijuana or cannabinoid-containing products for the purpose of medicinal use or recreational use, or both.

2017 Pharmacy at a glance (summary)

A publicly accessible summary of the 2015-17 detailed survey that FIP conducts every two years on the state of the pharmacy profession at the global level, giving an overview of topics ranging from the distribution of pharmacists in different sectors and access to pharmacies, to models of generic medicines dispensing/substitution and the availability of medicines online. The full report is available to FIP member organisations only.

2017 Reporting medicines shortages: Models and tactical options

An overview of some of the systems used to report medicines shortages around the world (eight medicines shortages reporting systems from six countries - Australia, Canada, Netherlands, Slovakia, South Africa and the USA) comparing a range of features such as the scope of the shortages listed, the criteria applied (such as the predicted duration of a shortage) and the sources of information used. This report is intended to support the implementation of the World Health Assembly Resolution on “Addressing the global shortage of medicines and vaccines” adopted in 2016.

2017 Pharmacy as a gateway to care: Helping people towards better health

This reference paper reviews the current state of consumer interest in health care and presents a collection of evidence of pharmacy services related to self care and the value that pharmacists bring to health care systems in this way. It lays out the drivers of self care and profound changes in the way health care systems operate.

2017 Medicines information: Strategic development

The first time that the implementation of medicines information, which is key to the safe and effective use of medicines, has been explored at a global level. Medicines information can be inaccurate, overwhelming, biased, unhelpful or simply not well understood. This publication sets out a vision for collaboration and action towards ensuring high quality medicines information around the world, through the use of strategies.

2016 An overview of current pharmacy impact on immunisation: A global report

The findings of a survey of 45 countries conducted by the FIP Collaborating Centre at University College London, and commissioned by FIP, offers offers an international overview of pharmacists’ activities to support immunisation. The report includes in-depth case studies from Argentina, Australia, Belgium, France, Ireland, Philippines, Portugal, South Africa, Switzerland, UK and USA, with advancement examples that can potentially be adopted by other countries to advocate for a national immunisation strategy that actively involves pharmacists as part of the public health agenda.

2016 Responding to disasters: Guidelines for pharmacy

The first global guidelines that support continued access to medicines and pharmacy expertise during natural disasters, such as floods, heat waves and earthquakes. This document was produced by FIP’s Pharmacy Emergency Management Working Group following extensive consultation.

2015 Establishing tobacco-free communities: A practical guide for pharmacists

This briefing document gives a number of examples from around the world, showcasing pharmacists’ value in performing health promotion, triage and referral as well as other interventions. It aims to make visible the contributions of pharmacists and provide a platform for future initia-tives that national pharmacy associations may run to support pharma-cists and the creation of well-designed interventions in pharmacies.

2015 Green pharmacy practice: Taking responsibility for the environmental impact of medicines

This reference document describes the different ways in which pharmaceuticals find their way into our water supplies, soil and atmosphere, and presents current findings on their levels in the environment. It also describes some of the negative effects that pharmaceuticals in the environment can have on living organisms and the actions that pharmacists have been taking to reduce their impact.

2015 Fighting antimicrobial resistance: The contribution of pharmacists

This briefing document reports what pharmacists have already been doing to avoid the further emergence of antimicrobial resistance, offering a menu of solutions drawn from around the world. These range from giving advice on influenza immunisation (thereby avoiding subsequent bacterial superinfections) and responsible prescribing of trimethoprim by pharmacists to treat urinary tract infections, to stewardship programmes to optimise antibiotic prescribing in hospitals, and the collection of left-over antibiotics.

2015 Focus on mental health: The contribution of the pharmacist

The briefing document gives an overview of the areas in mental health care in which pharmacists are involved, including health promotion, early detection, triage, optimising treatment outcomes, education (including addiction prevention), shaping public policies, research and interprofessional practice.

2015 Providing pharmaceutical care to migrant populations: Information and guidelines for pharmacists and the pharmacy

An FIP health advisory document to support the provision of pharmaceutical care to migrant populations. Additional tools include: - Software to convey medication instructions into Arabic - Leaflets to facilitate the dialogue between pharmacists and migrant patients: • German - Arabic • English - Arabic • French - Arabic • Spanish - Arabic - An example formulary for migrants into Europe (based on http://www.adler-apotheke-hh.de/fluechtlingsversorgung)

2015 All you need to know about spurious medicines

This handbook was produced by the World Health Professions Alliance in cooperation with the Indian Pharmaceutical Association. It contains tips on preventing and detecting counterfeit medicines as well as advice on how to minimise the threat and change behaviours.

2015 Advanced practice and specialisation in pharmacy: Global report

The first ever international overview of the extent of the advanced and specialised roles that pharmacists are undertaking, and the mechanisms supporting these developments. This reports expands the global evidence base on the global status of advanced and/or specialised pharmacy practice scopes and the models in which they exist, informing the implementation of Pharmaceutical Workforce Development Goal 4: Advanced and Specialist Development. Forty-eight countries and territories were surveyed to obtain country-level information regarding policy and implementation of advanced practice and specialisation. In addition, a series of seventeen country case studies were presented to illustrate an in-depth view of policy and implementation trends. The report outlines trends in policy development related to advanced and specialised roles, such as the development of national definitions, criteria and professional recognition systems.

2015 Key findings of the FIP advanced practice and specialisation in pharmacy: Global report

Summary of key findings of the “Advanced practice and specialisation in pharmacy: Global report, 2015”. The intention of this document is to provide helpful guidance and navigation for FIP’s stakeholders and to inspire FIP member organisations to consider strategy development and actions at national level, and to enable them to prepare briefings and communiqués for their own networks and stakeholders.

2014 Pharmacist ethics and professional autonomy: imperatives forkeeping pharmacy aligned with the public interest

Reference paper authored by FIP's Working Group on Pharmacist Ethics and professional autonomy.

2014 Ebola virus disease: Information and guidelines for pharmacists and the pharmacy workforce

Pharmacies are often the first point of contact with the health system for patients and people with health-related concerns. Designed to keep the whole pharmacy workforce well informed during the outbreak of the Ebola virus disease in West Africa countries in 2014, this “Information and guidelines” document includes suggestions for pharmacy activities for providing the crucial public health service of preventing the spread of the disease, and a list of reliable sources of additional information.

2013 International summit on medicines shortage

In 2013, FIP organised the International Summit on Medicines Shortage in Toronto, Canada, providing a forum to discuss the causes, impact and solutions to medicines shortages through a multi-stakeholder approach. The summit made six major recommendations. This report contains a summary of the discussions and recommendations from the summit.

2012 From making medicines to optimising outcomes: The evolution of a profession 1912-2012

This booklet contains an analysis describing and explaining the global development of community and hospital pharmacy in the context of the demographic and allied developments of the past century. It seeks to evaluate the challenges and opportunities facing pharmacy as both a regulated business and a healthcare profession at the start of of the 21st century, and to consider public interests in its ongoing evolution.

2011 Pharmacists’ contributions to diabetes care

This briefing document showcases the contributions of pharmacists in diabetes care. It gives a number of examples from around the world, presenting services for diabetes patients and pharmacists-led cam-paigns to celebrate World Diabetes Day. It aimed to provide a platform for future initiatives that national pharmacy associations may run to support pharmacists and the creation of well-designed interventions in pharmacies.

2011 The effective utilization of pharmacists in improving maternal, newborn and child health (2011, Hyderabad)
2009 Collaborative Practice (2009, Istanbul)
2006 WHO-FIP developing pharmacy practice handbook

A joint WHO-FIP publication on developing pharmacy practice, which aims to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. This handbook, which brings together practical tools and knowledge, was written in response to a need to define, develop and generate global understanding of pharmaceutical care at all levels.

No upcoming webinar or video or webinar video found.


FIP members To access video recordings of previous webinars, please go to the FIP Library

(login required).

A world of pharmacy data: Coming soon

This part of fip.org is still under construction. It will contain links to FIP’s online database of pharmacy-related information, organised into four categories (pharmacy and medicines regulation; pharmacy workforce and education; professional services and activities; and pharmacy remuneration models), as well as a compilation of examples of pharmacy campaigns, professional services and advocacy initiatives developed by FIP member organisations and other pharmacy-related bodies around the world.



Last update 10 May 2019

FIP Congresses